CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...
In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...
Hugely popular weight-loss jabs like Wegovy have been making headlines for enabling people to manage diabetes and excess weight along with other benefits, scientists say.Increasingly recommended by ...
Metsera, which is developing weight-loss drugs, said on Monday it is seeking a valuation of up to $1.78 billion in its U.S.
Eli Lilly's Ozempic-rivaling weight-loss pill orforglipron could be available in early 2026. Its retatrutide may be as ...
The Food and Drug Administration’s approval of Ozempic in 2021 for weight loss treatment ushered in a new era for the class ...